ConductScience.org, home

Paper6283496

Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities.

Bataille D and 6 others. Peptides, 1981. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities. Papers, record 6283496. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6283496

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities.
PubMed
Journal
Peptides
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
1.91
iCite
Revised in PubMed
2019-08-18
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bataille DD
2Gespach CC
3Tatemoto KK
4Marie JCJ C
5Coudray AMA M
6Rosselin GG
7Mutt VV

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastrointestinal HormonesMajor topic
Glucagon-Like PeptidesMajor topic
IleumMajor topic
JejunumMajor topic
Amino Acid Sequence
Animals
Cyclic AMP
Gastric Fundus
Glucagon
Oxyntomodulin
Peptide Fragments
Rats
Swine

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
40969875Ultrastable Insulin-Glucagon Fusion Protein Exploits an Endogenous Hepatic Switch to Mitigate Hypoglycemic Risk.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40969875PubMed
36932176Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases.Nat Rev Endocrinol2023https://conductscience.org/library/papers/36932176PubMed
34093449Proglucagon-Derived Peptides as Therapeutics.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34093449PubMed
33668627Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity.Nutrients2021https://conductscience.org/library/papers/33668627PubMed
31671667Methods and Guidelines for Measurement of Glucagon in Plasma.Int J Mol Sci2019https://conductscience.org/library/papers/31671667PubMed
30662430The Regulation of Peripheral Metabolism by Gut-Derived Hormones.Front Endocrinol (Lausanne)2018https://conductscience.org/library/papers/30662430PubMed
27856285Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke.Exp Neurol2017https://conductscience.org/library/papers/27856285PubMed
27713245Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options.Pharmaceuticals (Basel)2010https://conductscience.org/library/papers/27713245PubMed
25217372Can Bayliss and Starling gut hormones cure a worldwide pandemic?J Physiol2014https://conductscience.org/library/papers/25217372PubMed
25061485The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes.Prz Gastroenterol2014https://conductscience.org/library/papers/25061485PubMed
24749050Action and therapeutic potential of oxyntomodulin.Mol Metab2014https://conductscience.org/library/papers/24749050PubMed
24222092The role of gastrointestinal hormones in hepatic lipid metabolism.Semin Liver Dis2013https://conductscience.org/library/papers/24222092PubMed
23248172Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia.Diabetes2013https://conductscience.org/library/papers/23248172PubMed
23019069Unraveling oxyntomodulin, GLP1's enigmatic brother.J Endocrinol2012https://conductscience.org/library/papers/23019069PubMed
22899902Obesity and appetite control.Exp Diabetes Res2012https://conductscience.org/library/papers/22899902PubMed
22434197Bariatric surgery evolution from the malabsorptive to the hormonal era.Obes Surg2012https://conductscience.org/library/papers/22434197PubMed
11839727Gut adaptation and the glucagon-like peptides.Gut2002https://conductscience.org/library/papers/11839727PubMed
9741838GLP-1 receptors in golden Syrian hamster islets: identification and functional characterization.Endocrine1998https://conductscience.org/library/papers/9741838PubMed
6429938Immune aspects of intestinal metaplasia of the stomach: an immunohistochemical study.Virchows Arch A Pathol Anat Histopathol1984https://conductscience.org/library/papers/6429938PubMed
6207142Immunohistochemical studies on glucagon, glicentin and pancreatic polypeptide in human stomach: normal and pathological conditions.Histochem J1984https://conductscience.org/library/papers/6207142PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6283496

GET https://conductscience.org/api/papers/v1/6283496/cited_by?page=2